Nitrofurantoin-Induced Pulmonary Toxicity: Always Review the Medication List

Caitlin Batzlaff1, Matt Koroscil2

  • 1Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, USA.

Cureus
|September 21, 2020
PubMed

Insights

Nitrofurantoin is commonly used for urinary tract infections. A rare side effect, nitrofurantoin-induced pulmonary toxicity, can cause chronic pneumonitis, leading to breathing difficulties and low oxygen levels.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Infectious Diseases

Background:

  • Nitrofurantoin is a widely prescribed antibiotic for uncomplicated cystitis and recurrent urinary tract infections.
  • While generally safe, nitrofurantoin can cause adverse reactions affecting patient quality of life.
  • Pulmonary toxicity is a rare but significant side effect of nitrofurantoin therapy.

Observation:

  • This case report details a patient undergoing suppressive nitrofurantoin therapy.
  • The patient presented with symptoms of dyspnea (shortness of breath) and hypoxemia (low blood oxygen levels).

Findings:

  • The patient was diagnosed with chronic pneumonitis.
  • This condition was attributed to long-term nitrofurantoin use, highlighting a rare adverse effect.
  • The presentation involved varied clinical, imaging, and pathological findings consistent with drug-induced lung injury.

Implications:

  • Clinicians should consider nitrofurantoin-induced pulmonary toxicity in patients on long-term therapy presenting with respiratory symptoms.
  • Early recognition and discontinuation of the drug are crucial for managing this rare side effect.
  • This case underscores the importance of monitoring for adverse reactions to common medications like nitrofurantoin.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
308
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
184
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
158
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
105
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
373
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131